Navigation Links
Dr. Andrew Advani receives Diabetes Innovation Award
Date:12/29/2011

TORONTO, Ont., Dec. 29, 2011--Dr. Andrew Advani, an endocrinologist at St. Michael's Hospital, is one of 10 researchers in North America who received a newly created Novo Nordisk Diabetes Innovation Award.

Dr. Advani's Early Exploration Award is worth $325,000 (U.S.) over two years.

His research focus is to slow and potentially reverse kidney damage in patients suffering from diabetes. In diabetic kidney disease, the tiny filters in the kidney known as glomeruli become damaged and begin to leak proteins into the urine.

This award will enable Dr. Advani to investigate new ways to slow or even prevent kidney damage that leads to protein leakage. Through his studies, Dr. Advani hopes to develop new treatments to prevent kidney injury in diabetes, currently the most common cause of kidney disease worldwide.

Dr. Advani's research project was selected from more than 80 proposals submitted from U.S. and Canadian research institutions.

Novo Nordisk is an international healthcare company based in Denmark recognized as a world leader in diabetes treatment. The Novo Nordisk Diabetes Innovation Award Program was launched in 2011 to help scientists substantiate early research efforts that could result in new treatment options for diabetes and obesity.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Page: 1

Related medicine news :

1. Counseling Suicidal Clients by Andrew Reeves
2. Cedars-Sinai Medical Center Names Beverly Hills Plastic Surgeon Dr. Andrew Cohen as Chief of the Center for Plastic and Reconstructive Surgery
3. Andrew J. Dannenberg, M.D., honored with AACR-Prevent Cancer Foundation Award
4. NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education
5. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
6. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
7. BestMassage.com Receives Award for Customer Trust
8. Corporate Wellness Firm Limeade Receives SAS 70 Type II Report
9. Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award
10. Special Olympics Georgia Receives Grant from The Home Depot Foundation
11. NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for certain ... Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: